10.3390/ijms24043380 Int
The majority of pharmacological interventions for liver fibrosis are currently in Phase II and III of preclinical trials [54]
Proposed Changes to the MS-LTC-DRGs for FY 2024 As specified by our regulations at 412.517(a), which require that the MS-LTC-DRG classifications and relative weights be updated annually, and consistent with our historical practice of using the same patient classification system under the LTCH PPS as is used under the IPPS, in this proposed rule, we are proposing to update the MS-LTC-DRG classifications effective October 1, 2023 through September 30, 2024 (FY 2024) consistent with the proposed changes to specific MS-DRG classifications presented in section II.F
Preliminary studies suggest that ALA may have direct anti-cancer effects, such as inhibiting cancer cell growth, inducing apoptosis (programmed cell death), and preventing angiogenesis (the formation of new blood vessels that supply tumors)
National Institute of Environmental Health Science
Consider NAC, MSM, or glutathione if sulfur is low
